Tag Philadelphia

Investigators at University of Pennsylvania Target Drug Delivery Systems (Advanced drug delivery systems for antithrombotic agents)

Oct27

By a News Reporter-Staff News Editor at Clinical Trials Week A new study on Drugs and Therapies is now available. According to news reporting originating from Philadelphia, Pennsylvania, by NewsRx correspondents, research stated, “Despite continued achievements in antithrombotic pharmacotherapy, difficulties remain in managing patients at high risk for both thrombosis and hemorrhage. Utility of antithrombotic […]

BRIEF: Phoenixville doctor charged with tax fraud [The Philadelphia Inquirer :: ]

Mar28

March 28A Phoenixville doctor has been charged with federal tax fraud for allegedly pocketing millions he earned from online prescription sales but never reported as income.In an indictment unsealed Thursday, the U.S. Attorney’s Office in Philadelphia said Elias Karkalas earned about $2.5 million from prescriptions to patients he never met or examined.Karkalas, 64, a primary-care […]

Philadelphia Personal Injury Lawyer Randall C. Flager Comments On Pennsylvania Drug Overdose Death Statistics

Nov12

Philadelphia, PA (PRWEB) November 12, 2013 Philadelphia personal injury attorney Randall C. Flager of Flager & Associates, PC today said drug manufacturers must do more to keep consumers safe in the wake of a recent study showing Philadelphia has the 14th highest rate of drug overdose deaths in the nation.CBS Philly (Pa. Ranked 14th In […]

Echo Therapeutics Hires Product Development Management Executive

Oct11

PHILADELPHIA, Oct. 11, 2011 /PRNewswire/ Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude SkinPrep System for transdermal drug delivery, today announced that Samir Farah, who has more than fifteen years of medical product design and development experience, has […]

New Findings in Biochemistry Described from Fox Chase Cancer Center

Sep28

A new study, "The benefits and challenges associated with the use of drug delivery systems in cancer therapy," is now available. "The use of drug delivery systems as nanocarriers for chemotherapeutic agents can improve the pharmacological properties of drugs by altering drug pharmacokinetics and biodistribution. Among the many drug delivery systems available, both micelles and […]

Echo Therapeutics to Present at the JMP Securities Healthcare Conference

Sep20

PHILADELPHIA, Sept. 20, 2011 /PRNewswire/ Echo Therapeutics, Inc. (NASDAQ: ECTE), a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., CEO, President and Chairman of the Board of Echo Therapeutics will present […]

Echo Therapeutics Receives Registered Trademarks for Symphony and Prelude

Sep15

PHILADELPHIA, Sept. 15, 2011 /PRNewswire/ Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude SkinPrep System for transdermal drug delivery, today announced that the company has received Certificates of Registration from the United States Patent and Trademark Office […]

Echo Therapeutics Initiates Clinical Trial of its Symphony Continuous Glucose Monitoring System

Sep8

PHILADELPHIA, Sept. 8, 2011 /PRNewswire/ Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing the Symphony? tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude? SkinPrep System for transdermal drug delivery, today announced that it is initiating a clinical study of its Symphony tCGM System. The company expects to complete […]

Echo Therapeutics to Present at the Rodman & Renshaw Annual Global Investment Conference

Sep7

PHILADELPHIA, Sept. 7, 2011 /PRNewswire/ Echo Therapeutics, Inc. (NASDAQ: ECTE), a company developing its needle-free Symphony? tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude? SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., CEO, President and Chairman of the Board of Echo Therapeutics will present […]

Echo Therapeutics to Present at the Stifel Nicolaus Healthcare Conference 2011

Aug31

PHILADELPHIA, Aug. 31, 2011 /PRNewswire/ Echo Therapeutics, Inc. (NASDAQ: ECTE), a company developing its needle-free Symphony? tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude? SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., CEO, President and Chairman of the Board of Echo Therapeutics will present […]